Atlas market file · Etf · United States
iShares Emerging Markets Dividend Index Fund Exchange Traded FundDVYE
- Last close
- 34.24
- Change
- +0.23%
- 96-bar range
- 31.86 – 35.95
- As of
- 7 Aug 2026
iShares Emerging Markets Dividend Index Fund Exchange Traded Fund is an exchange-traded fund listed as DVYE on AMEX. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (+22.99% over the window).
Source rail: Yahoo Finance chart API (DVYE). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for DVYE. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
DVYE public profile
Exchange-traded fund. iShares Emerging Markets Dividend Index Fund Exchange Traded Fund is connected to current market context, cited company sources and its retained research file.
iShares Emerging Markets Dividend Index Fund Exchange Traded Fund trades as DVYE on AMEX. iShares Emerging Markets Dividend Index Fund Exchange Traded Fund (DVYE) has a latest verified close of 34.24, up 0.23%, dated 7 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. DVYE stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
What changed for iShares Emerging Markets Dividend Index Fund Exchange Traded Fund today
iShares’ Emerging Markets Dividend ETF (DVYE) is marketed as a way to capture "growth and income potential" from less-developed economies, but the fund’s glossy pitch masks a simple truth: it’s a fee-driven wrapper that owns a rules-based basket of dividend-paying companies, primarily in Poland, Taiwan, and South Korea. The issuer’s product pages and comparison tools emphasise global reach and regulatory coverage, yet the fine print explicitly states that most UK regulatory protections do not apply to DVYE, leaving investors to rely on the fund’s domicile, the exchange it lists on, and the issuer’s own risk management. The fund’s official ETF centre and product pages confirm its identity as an iShares fund domiciled outside the UK, with protections provided by the regulatory system where it is authorised-not the UK’s (source: iShares UK - BlackRock, https://www.ishares.com/uk/individual/en/products/ai-etfs).
The fund’s mandate is to track the Morningstar® Emerging Markets High Dividend Yield Index, which means it’s not picking stocks based on some crystal-ball vision of future growth-it’s simply hoovering up the highest-yielding dividend payers in the index’s universe. The issuer’s comparison tool lets you pit DVYE against other iShares funds, but it’s not a fair fight: the protections and regulatory safeguards you’d expect from a UK-domiciled fund are largely absent here. The fund’s top holdings read less like a global dividend safari and more like a polite dinner party with Europe’s stodgy incumbents, with the largest positions in Polish banks, Taiwanese tech suppliers, and South Korean conglomerates (source: Fund Comparison | iShares - BlackRock, https://www.ishares.com/uk/individual/en/products/compare-funds?switchLocale=y&siteEntryPassthrough=true).
DVYE’s expense ratio is 0.45%, which sits in the middle of the road for emerging-market dividend ETFs but is still a fee you’re paying to own a basket that could be assembled by a spreadsheet-wielding intern. The issuer’s product pages and comparison tools emphasise global reach and regulatory coverage, yet the fine print explicitly states that most UK regulatory protections don’t apply to DVYE, leaving investors to rely on the fund’s domicile, the exchange it lists on, and the issuer’s own risk management-none of which are UK-regulated safety nets. The fund’s marketing leans on the idea of "exposure to various asset classes," but the actual portfolio is a rules-based, index-tracking basket of dividend payers, filtered through Morningstar’s methodology and BlackRock’s fee engine (source: Exchange-Traded Funds (ETFs) | iShares UK - BlackRock, https://www.ishares.com/uk/individual/en/products/ai-etfs).
DVYE is listed on Nasdaq, where you can track its market activity, but the fund’s regulatory domicile and the protections it carries are not UK-specific. The issuer’s product pages and comparison tools confirm that iShares products domiciled in Europe are listed on principal European stock exchanges, but the protections provided by the UK regulatory system do not apply to their operation. The fund’s official ETF centre and product pages do not reveal its current asset-under-management (AUM) or liquidity metrics, so the source requires readers to rely on the issuer’s marketing and the exchange’s data for visibility (source: DVYE ETF listing and market activity, https://www.nasdaq.com/market-activity/etf/dvye).
Sources & evidence · 8 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
DVYE technical readout
Directional bias up. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on DVYE
FreedomCore Atlas can expand this public profile into source-led research files with holdings and concentration, index methodology, exposure and overlap, fees and tracking difference, and liquidity context. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep DVYE research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
DVYE FAQ
What is iShares Emerging Markets Dividend Index Fund Exchange Traded Fund (DVYE)?iShares Emerging Markets Dividend Index Fund Exchange Traded Fund (DVYE) has a latest verified close of 34.24, up 0.23%, dated 7 Aug 2026. Use this page to check the...
iShares Emerging Markets Dividend Index Fund Exchange Traded Fund (DVYE) has a latest verified close of 34.24, up 0.23%, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for DVYE?iShares Emerging Markets Dividend Index Fund Exchange Traded Fund (DVYE) has a latest verified close of 34.24, up 0.23%, dated 7 Aug 2026. It brings the latest...
iShares Emerging Markets Dividend Index Fund Exchange Traded Fund (DVYE) has a latest verified close of 34.24, up 0.23%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. DVYE stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
How often is the DVYE page updated?The DVYE public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The DVYE public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for DVYE?The DVYE file starts with Nasdaq Trader and TradingView AMEX:DVYE. The page separates verified market context from company evidence and shows open evidence gaps instead...
The DVYE file starts with Nasdaq Trader and TradingView AMEX:DVYE. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on DVYE?Yes. The workstation can open DVYE, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open DVYE, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this DVYE page investment advice?No. The DVYE page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The DVYE page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
DVYE
Etf · evidence first